DRUG Earnings & Financial Statements
Bright Minds Biosciences Inc.
$55.13
+$4.41(+8.71%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$497.95M
Volume
47.71K
52W Range
$47.23 - $123.75
Target Price
$154.83
DRUG earnings and financial statements: Bright Minds Biosciences Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
DRUG Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$13.94M | -$2.82M | -$7.39M | -$14.98M |
| EBITDA | -$12.15M | -$2.71M | -$7.33M | -$14.96M |
| Net income | -$12.23M | -$2.78M | -$7.40M | -$14.96M |
| EPS (diluted) | $-1.78 | $-0.65 | $-1.98 | $-1.21 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $84.42M | $6.10M | $6.88M | $12.09M |
| Total liabilities | $2.38M | $568.3K | $280.9K | $1.54M |
| Shareholders’ equity | $82.04M | $5.54M | $6.60M | -$24.17M |
| Cash and equivalents | $82.91M | $5.72M | $6.75M | $11.63M |
| Long-term debt | $41.2K | $39.6K | - | $72.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$8.69M | -$1.85M | -$7.02M | -$13.59M |
| Free cash flow | -$8.69M | -$1.85M | -$7.02M | -$13.59M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DRUG | $55.13 | +8.7% | 47.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bright Minds Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW